top of page

Latest News

24 nov 2023

BioFicher releases expanded end-to-end Clinical Trial Tokenisation solution

BioFicher announces the release of its next generation Clinical Trial Tokenisation solution.

BioFicher releases expanded end-to-end Clinical Trial Tokenisation solution

15 nov 2023

LEO Pharma and BioFicher enter a strategic partnership to propel clinical trial execution within medical dermatology.

Leo Pharma Group and BioFicher Sciences today announced a strategic partnership to improve dermatology patients' lives through innovative clinical trials.

LEO Pharma and BioFicher enter a strategic partnership to propel clinical trial execution within medical dermatology.

22 mrt 2023

BioFicher selected by BARDA to conduct anthrax vaccine clinical trial.

BioFicher announces that it has been selected by BARDA, part of the ASPR, in the Department of HHS, to execute an anthrax vaccine clinical trial.

BioFicher selected by BARDA to conduct anthrax vaccine clinical trial.

20 mrt 2023

Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health Programs

Partnership Aims to Advance Daré’s Reproductive Health Portfolio in a Timely and Capital Efficient Manner

Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health Programs

19 mrt 2023

BioFicher establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses

BioFicher establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses.

BioFicher establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses

18 mrt 2023

8 Cost Containment Strategies for Rare Disease Clinical Trials

Here are 8 strategies to help contain clinical development costs in rare disease research, without compromising on quality.

8 Cost Containment Strategies for Rare Disease Clinical Trials

bottom of page